Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation

Transplant Proc. 1999 Feb-Mar;31(1-2):1160-1. doi: 10.1016/s0041-1345(98)01945-9.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Azathioprine / therapeutic use
  • Creatinine / blood
  • Cyclosporine / adverse effects*
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / drug therapy
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney / drug effects*
  • Kidney / pathology
  • Kidney Function Tests
  • Lung Transplantation / immunology*
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Survival Rate
  • Tacrolimus / therapeutic use

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine
  • Mycophenolic Acid
  • Azathioprine
  • Tacrolimus
  • Methylprednisolone